This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Vertex nets $390.1mm through sale of common shares and debt
26 Feb 2008
Vertex Pharmaceuticals (infectious and immune diseases and cancer) has netted $112.1mm through the follow-on public offering of 6.9mm common shares (including the overallotment) at $17.14. The company also concurrently netted $278.5mm by selling 4.75% five-year convertible senior subordinated notes which convert into 43.22 common shares per $1k in notes (about $23.14 per share).
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?